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Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and
mortality worldwide. While the primary risk factor for COPD is cigarette smoke exposure,
vitamin D deficiency has been epidemiologically implicated as a factor in the progressive
development of COPD-associated emphysema. Because of difficulties inherent to studies
involving multiple risk factors in the progression of COPD in humans, we developed
a murine model in which to study the separate and combined effects of vitamin D
deficiency and cigarette smoke exposure. During a 16-week period, mice were exposed
to one of four conditions, control diet breathing room air (CD-NS), control diet with
cigarette smoke exposure (CD-CSE), vitamin D deficient diet breathing room air (VDD-NS)
or vitamin D deficient diet with cigarette smoke exposure (VDD-CSE). At the end of
the exposure period, the lungs were examined by a pathologist and separately by
morphometric analysis. In parallel experiments, mice were anesthetized for pulmonary
function testing followed by sacrifice and analysis. Emphysema (determined by an
increase in alveolar mean linear intercept length) was more severe in the VDD-CSE
mice compared to control animals and animals exposed to VDD or CSE alone. The
VDD-CSE and the CD-CSE mice had increased total lung capacity and increased static
lung compliance. There was also a significant increase in the matrix metalloproteinase-9:
tissue inhibitor of metalloproteinases-1 (TIMP-1) ratio in VDD-CSE mice compared with
all controls. Alpha-1 antitrypsin (A1AT) expression was reduced in VDD-CSE mice as
well. In summary, vitamin D deficiency, when combined with cigarette smoke exposure,
seemed to accelerate the appearance of emphysemas, perhaps by virtue of an increased
protease-antiprotease ratio in the combined VDD-CSE animals. These results support the
value of our mouse model in the study of COPD.
Keywords: emphysema, vitamin D deficiency, second hand cigarette smoke, matrix metalloproteinase-9, tissue
inhibitor of metalloproteinase-1, alpha-1 antitrypsin, chronic obstructive pulmonary disease, Teague smoke
exposure device
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is the third lead-
ing cause of chronic morbidity and mortality in the United
States and is projected to rank fifth in 2020 in burden of disease
worldwide (Rabe et al., 2007). Smoking, the main risk factor for
COPD (Stockley et al., 2009), is a powerful inducer of inflamma-
tory mediators, including oxidants and proteases (Spurzem and
Rennard, 2005). The increased activity of proteases is important
given that protease-antiprotease imbalance plays a key pathogenic
role in the development of emphysema in COPD. In this regard,
alpha-1-antitrypsin (A1AT) is the prototypical member of the
serine protease inhibitor (serpin) superfamily of proteins, which
have a major role in inactivating neutrophil elastase and other
proteases to maintain protease-antiprotease balance (Lomas and
Mahadeva, 2002). Alpha-1 antitrypsin deficiency (AATD), a
genetic disease resulting in low levels of antiproteases, is a
risk factor for emphysema, which supports the importance of
protease-antiprotease balance in the pathogenesis of emphysema
(Sandhaus, 2010). Another family of proteolytic enzymes, the
matrix metalloproteinases (MMPs), and their inhibitors, tissue
inhibitor of metalloproteinases (TIMPs), are involved in remod-
eling the extracellular matrix and in host defense (Elkington and
Friedland, 2006) and are also associated with tissue destruction in
emphysema (Abboud and Vimalanathan, 2008).
Although smoking and age are major determinants of lung
function (as measured by the forced expiratory volume in 1 s;
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FEV1), there is an epidemiologic association between low serum
concentrations of 25-hydroxy vitamin D and lung function (Black
and Scragg, 2005). There is also an association between disease
severity and genetic variability in vitamin D pathway genes found
in cross-sectional studies of patients with COPD (Janssens et al.,
2010). Indeed, there is increasing evidence for diverse roles for
vitamin D, such as innate immunity andmuscle strength that may
contribute to respiratory health (Hughes and Norton, 2009). In
a recent single center, double-blind study using high dose vita-
min D supplementation, patients who entered the study with
severe vitamin D deficiency, experienced fewer COPD exacer-
bation events after vitamin D supplementation (Lehouck et al.,
2012). The results of this interventional study contrast with
another study in which there were no differences in baseline vita-
min D levels between smokers with rapid vs. slow declines in
lung function over approximately 6 years of prospective follow-
up (Kunisaki et al., 2011). This non-interventional study was
limited—only one vitamin D measurement was made at the
start of the study period. Thus, nothing is known about vita-
min D intake or levels during the subsequent period of dis-
ease progression. Although there is increasing interest in vita-
min D and lung disease, two important questions remain unan-
swered. First, can vitamin D deficiency act as a contributing
risk factor for emphysema? Second, what are the mechanisms
whereby reduced levels of vitamin D could directly influence
the pathogenesis of emphysema? Putative mechanisms include
immune modulation and lung tissue remodeling (Janssens et al.,
2009).
Given the multitude of confounding factors, it is difficult to
address any potential cooperative link between vitamin D defi-
ciency and susceptibility to lung injury by cigarette smoke in
humans. Therefore, we developed an animal model to study
the separate and combined effects of vitamin D deficiency and
cigarette smoke exposure on lung structure and function. We
believe that this model provides a useful platform to investigate
the individual and joint mechanisms that contribute to complex
lung disorders.
MATERIALS AND METHODS
MICE, DIET, AND SMOKE-EXPOSURE
All aspects of the mouse protocol were approved by the
Dartmouth Institutional Animal Care and Use Committee and/or
the White River Junction VA Institutional Animal Care and Use
Committee (IACUC). All mice were purchased from the National
Cancer Institute at 5–6 weeks of age. Mice were housed with
12-hour dark and light cycles and given free access to food and
water. Mice were weighed weekly and monitored for changes in
health status. In early experiments, cigarette smoke exposed male
mice became aggressive and were excluded from study for that
reason. Therefore, we studied female FVB mice, a strain used
in cigarette exposure experiments (Keith et al., 2004; Siddens
et al., 2012). The animals were fed either a vitamin D defi-
cient diet (VDD) or a vitamin D replete diet as a control (CD)
(Harlan-Teklad,Madison, WI, USA; VDD number TD.09498 and
CD number TD.09499) beginning at 6 weeks of age. The vita-
min D replete diet contained 2.2 i.u vitamin D3/gm of food.
Assuming mice consume ∼3 gms of food per day, the control
diet animals received near the upper limit of the acceptable
daily dose of vitamin D recommended by the Endocrine Society.
Because of the effect of vitamin D on lung structure in devel-
oping mice (Zosky et al., 2011), we started dietary restriction
at six weeks of age when development has progressed beyond
the alveolar stage of lung growth (Backstrom et al., 2011). Six
weeks after beginning each diet, mice were exposed to a com-
bination of second hand cigarette smoke (89%) and primary
cigarette smoke (11%) produced in a Teague-TE10 smoke expo-
sure device (Griffith and Hancock, 1985) (Teague Enterprises,
Woodland, CA), using Research Cigarettes 3R4F (University of
Kentucky College of Agriculture Reference Cigarette Program,
Lexington, KY), for 4 h/day, 5 days/week, for 16 weeks. The aver-
age Total Suspended Particle (TSP) content within the chamber
was 75mg/m3. Control mice breathed filtered air and had han-
dling similar to smoke-exposed mice. Chronic smoke exposures
were conducted in four different experiments each with 48 mice
randomly divided into the four treatment groups.
Vitamin D levels were confirmed either by Enzyme
Immunoassay (EIA) according to the manufacturer’s instructions
(Immunodiagnostic Systems Ltd., Fountain Hills, AZ) or by
outside laboratories (Dartmouth Reference Laboratory, Lebanon
NH or ZRT Laboratory, Beaverton, OR). We sent samples to two
outside laboratories to confirm our initial findings. Results from
the two labs were consistent.
We studied the effects of two interventions, vitamin D defi-
ciency and cigarette smoke exposure. Mice were randomly
assigned to one of four treatment groups; control diet-non smoke
exposed (CD-NS), control diet-cigarette smoke exposed (CD-
CSE), vitamin D deficient-non smoke exposed (VDD-NS) and
vitamin D deficient-cigarette smoke exposed (VDD-CSE). The
results of this study were analyzed with a Two-Way ANOVA
design in which each treatment (cigarette smoke exposure and
vitamin D-deficiency) was a between subjects factor. When the
ANOVA indicated that significant differences existed among
treatment groups, specific pre-planned comparisons were made
using P-values adjusted by the Bonferroni method. Data were
reported as the mean ± the standard error of the mean (SEM).
RESPIRATORY MECHANICS
For pulmonary function testing, each mouse was anesthetized
by intraperitoneal (i.p.) injection of Xylazine hydrochloride
(10mg/kg) and pentobarbital sodium (50mg/kg). Tracheostomy
was performed using a 19-gauge cannula and secured with suture
ties. Animals were mechanically ventilated with a tidal volume of
10ml/kg at a frequency of 150 breaths/min using a computer-
controlled volume ventilator (flexiVent™, SCIREQ, Montreal,
PQ) against a positive end-expiratory pressure (PEEP) of 3 cm
H2O. To facilitate measurements of respiratory mechanics, anes-
thetized animals were paralyzed with pancuronium bromide
(0.5mg/kg i.p.). To ensure adequate anesthesia, heart rate was
monitored with a continuous electrocardiogram tracing.
The flexiVent™ system uses a forced oscillation method to cre-
ate pressure-volume curves in anesthetized animals to measure
respiratory system mechanics (Bates and Suki, 2008; Vanoirbeek
et al., 2010). The measured variables were fitted to a variety of
models depending on the particular stimulus, and the measures
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of respiratory mechanics were derived from the parameters in
each model. For example, the Snapshot-150 perturbation used a
fixed frequency (2.5 Hz) pressure oscillation applied at the tra-
chea, and measurements of respiratory system resistance [R],
and compliance [C] were derived from these pressure oscillations
using a single compartment model with an equation of motion
dependent only on flow and volume. The Quick-prime-3 per-
turbation consisted of a multiple frequency pressure oscillation
used to calculate the input impedance of the respiratory system.
From the impedance measurement, estimates of airway resis-
tance [Rn], tissue damping [G], and tissue elasticity [H] were
made using a constant phase model. Finally, pressure-volume
curves were used to measure static compliance [Cst], total lung
capacity [TLC], and hysteresis [Area]. All of the fitted param-
eters were calculated using flexiVent™ software. The flexiVent™
system has been widely used to make measurements of respi-
ratory mechanics in mice and has been validated in chronic
measurements of respiratory mechanics in mice by comparing
measurements derived from the flexiVent™ system to more tradi-
tional measurements of respiratory mechanics (De Vleeschauwer
et al., 2011).
LUNG PATHOLOGY
To preclude the possibility of confounding effects from the mea-
surements of respiratory mechanics, the analysis of lung pathol-
ogy, including morphometric data and images, came from mice
that were not studied by flexiVent™, and alternate groups of mice
were selected for analysis of lung pathology or lung mechanics.
Mice selected for analysis of lung pathology were euthanized by
cardiac puncture to avoid the potential effects of CO2 asphyxi-
ation on atelectasis. Lungs were inflated at 20 cm H2O pressure
with a 2.5% gluteraldehyde solution. Blocks of fixed tissue were
excised, placed in cassettes and set in paraffin. Hematoxylin and
eosin stained slides were examined by light microscopy with 4×,
10× and 20× magnification with a standard Olympus micro-
scope by a board certified surgical pathologist.
The pathologist was blinded to the treatment group of each
animal. The presence/absence and degree of emphysema, acute
neutrophilic inflammation of the tubular airways (bronchi and
bronchioles), chronic (mainly lymphocytic) inflammation of the
tubular airways, chronic parenchymal inflammation (of spongy
alveolar tissue), pigmented macrophages within tubular airways,
and pneumocyte cell hyperplasia (without further interpretation
as pre-neoplastic or reactive) was recorded for each mouse lung. A
four tiered score (0, +, ++, + + +) was recorded for each of the
morphological features. Zero, meaning the finding was absent in
the lung tissue on the H&E slide, +, meaning that the finding was
focal (limited to either one tubular airway or 1 high power field
(HPF) of parenchyma), ++, meaning the finding was present
in two tubular airways or 2 separate HPF’s or parenchyma, and
+ + +, meaning the finding was present in 3 or more tubular
airways or HPFs. Pigmented macrophages, which are commonly
seen in human smokers and called “smokers macrophages” are
associated with “smokers bronchiolitis” or “respiratory bronchi-
olitis” and were characterized by the presence of macrophages
containing dusty brown non-hemosiderin pigment in tubular air-
ways (Couture and Colby, 2003). Pneumocyte hyperplasia was
scared based on an increase in the size and shape of alveolar pneu-
mocytes. The pathological scores ranged from 0 to 2+, and there
were few 2+ scores. For that reason, the scores in each mouse
were converted to ordinal data: the simple presence or absence
of the pathological finding, and the presence (1) or absence (0) of
each particular pathological finding was compared among groups
using a non-parametric, One-WayANOVA (Kruskal–Wallis Test).
HISTOMORPHOMETRIC ANALYSIS
Mean Linear Intercept (LM) is a reflection of the mean air space
diameter (Hsia et al., 2010). This variable was chosen to give addi-
tional information about alveolar abnormalities, observed as air
space enlargement (Heemskerk-Gerritsen et al., 1996; Robbesom
et al., 2003; Jacob et al., 2009). Images (JPEG) of histological
sections of the glutaraldehyde fixed lungs were taken using a
Diagnostic Instruments, Inc., 11.2 Color Mosaic digital camera
(at 1600 × 1200 pixel resolution) using the SPOT Basic software,
a 40× objective lens, and a 10× eyepiece on an Olympus BX50
microscope. We calculated that 2.764 pixels at this magnification
were equal to one micron. From each lung section, ten random
pictures were analyzed.
In Matlab® (a high-level technical computing language), each
image was automatically separated into two color planes (tissue
and white space) using K-means clustering (partitioning algo-
rithm). White spaces with areas of less than 500 pixels were
excluded from this analysis so as to avoid measuring vessels and
stray white pixels. In parallel horizontal lines 25 microns (69 pix-
els) apart, transitions from airspace to tissue were automatically
counted, as was the total distance measured (28,800 pixels, or
10,420 microns). The mean linear intercept (LM) in each image
was then calculated in microns according to:
LM = (N × l)∑
I
whereN is the number of times the line is placed on the image, l is
the length of each line and
∑
I is the total number of transitions
from airspace to tissue measured.
QUANTITATIVE PCR
For gene expression studies in the lung, we selected genes known
to be involved in development of emphysema. Tissues for mRNA
analysis were prepared from excised lungs that were placed in
RNAlater® (Qiagen, Valencia, CA) and frozen at -80 C. RNA was
extracted from each sample using RNeasy® (Qiagen, Valencia,
CA). One microgram of RNA was reverse transcribed to cDNA
using an iScript™ kit (Bio-Rad, Hercules, CA) and amplified by
real time PCR using SYBR green master mix (Bio-Rad, Hercules,
CA). Gene expression levels were normalized to mouse house-
keeping gene RPL13a (MHK) expression. The primer sets used
are shown in Table 1. Quantification was determined using the
software Opticon Monitor software version 3.1.
RESULTS
VITAMIN D LEVELS ARE DECREASED IN VDD MICE
To confirm that the vitamin D deficient diet resulted in low
vitamin D levels, we measured vitamin D levels in all mice. All
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vitamin D levels were measured at the conclusion of each study at
the time of sacrifice. The mean serum level of 25-hydroxyvitamin
D3 in CD-NS mice was 18.2 ± 11.2 ng/mL and in CD-CSE it was
19.9 ± 9.8 ng/mL. Mice on the vitamin D deficient diet had lev-
els of <5 ng/mL in both NS and CSE conditions (Figure 1). Thus,










F, forward; R, reverse; TIMP, tissue inhibitor of metalloproteinases; MMP, matrix
metallopeptidase; A1AT, alpha 1-antitrypsin or α1-antitrypsin.
FIGURE 1 | 25-hydroxyvitamin D levels in the four treatment groups at
the end of the experimental period. Values shown reflect means ± SEM
of 19–23 mice per group. Levels of 25-hydroxyvitamin D in mice fed control
diets were significantly different than mice fed a vitamin D deficient diet
(p = 0.001).
levels of 25-hydroxyvitamin D in mice fed control diets were sig-
nificantly greater than 25-hydroxyvitamin D levels in mice fed a
vitamin D deficient diet (p = 0.001).
PATHOLOGY
In order to explore the effect of CSE on lung architecture and
the frequency of pathological findings within the lung, the histo-
logical slides were examined in a blinded fashion. Representative
sections are shown in Figure 2 and summary statistics, based on
the presence or absence of specific pathological features in each
treatment group, are shown in Table 2. Statistically significant
differences were noted between treatment groups in the occur-
rence of pigmented macrophages within small airways in 8 of
11 of the VDD-CSE group and in 5 of 11 of the CD-CSE mice
(p < 0.05 for both groups compared to control, CD-NS animals).
No pigmented macrophages were noted in sections of lung of the
mice breathing filtered room air. There were only rare instances
of acute neutrophilic inflammation in any of the specimens, but
chronic inflammation, indicated by the presence of lymphocytic
inflammatory infiltrates, was seen sporadically in all groups of
mice. However, none of the other pathological features differed
significantly among groups.
FIGURE 2 | Normal and emphysema-like features in hematoxylin and
eosin (H&E) stained sections of lung representative of lung sections
from each treatment group. All images are 40× enlargements.
Table 2 | Histological review of mouse lungs.
Airway Parenchymal Pigmented Pneumocyte
inflammation (%) inflammation (%) macrophages (%) hyperplasia (%)
CD-NS 44 78 0 22
VDD-NS 55 73 18 45
CD-CSE 0 67 75* 0
VDD-CSE 36 55 91* 18
Sections of H&E-stained mouse lung were reviewed for the presence/absence of the four histologic features indicated in Table 2. The frequency of occurrence of
these features is represented as percentages of animals within each treatment group in which the histological feature was observed. All of the inflammation in
these cases was chronic (lymphocytic); there were no cases that showed acute (neutrophil) cells. *Indicates a significant increase in a particular feature compared
to control animals (CD-NS) at the p < 0.05 level.
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MORPHOMETRIC ANALYSIS REVEALS ENLARGEMENT OF AIR SPACES
IN VDD-CSE MICE
Morphological measurements represent a useful, unbiased
method to characterize emphysematous lesions in a semi-
quantitative manner (Robbesom et al., 2003). Enlargement of air
spaces was evaluated by the Mean Linear Intercept (LM) mea-
surement technique (Thurlbeck, 1967). Based on analysis of 10
images from each lung section of each of eleven mice in each of
the four treatment groups (440 total images analyzed), mice with
VDD-CSE treatments had significantly longer mean linear inter-
cept (LM) distance (36.27µ ± 0.88) compared to animals in the
other three groups (Figure 3). CD-NS MLI was 32.93µ (±0.37,
p = 0.0006). VDD-NS was 33.32µ (±0.47, p = 0.0037) and CD-
CSE was 29.08µ (±0.487, p = 0.00001). Thus, VDD-CSE mice
had the greatest morphometric air space enlargement, consistent
with a contribution of vitamin D deficiency to the development
of emphysema.
It is surprising that the CD-CSE animals had, on average,
a normal LM . The analysis was, however, confounded by the
co-occurrence of accumulations of macrophages. As shown in
Table 1, there was a striking increase in the number of animals
with increased alveolar macrophages in the airspace among the
smoke exposed animals. The measurement of LM was automated
to preclude bias and measured airspace size—not inter-septal dis-
tances across alveoli (which is consistent with the ATS Standards
for Quantitative Assessment of Lung Structure; (Hsia et al., 2010),
and these standardized measurement methods of are specifi-
cally meant to exclude changes in septal thickens). Moreover,
others have noted that smoke exposure in mice may increase
macrophage numbers (Hirama et al., 2007). Thus, increased
macrophage accumulation in the alveolar airspace in the CD-
CSE animals may have reduced the measured LM despite the
FIGURE 3 | Mean Linear Intercept (LM ) in experimental groups. Levels
shown reflect means ± SEM. LM is significantly longer in VDD-CSE mice
compared to all other treatment groups and is consistent with emphysema.
Data shown are based on analyses of 10 images from each lung section of
each of eleven mice in each of the four treatment groups (440 total images
analyzed).
presence of alveolar enlargement shown in some regions of the
lung (Figure 2, CD-CSE example).
MICE EXPOSED TO CIGARETTE SMOKE HAVE ALTERED RESPIRATORY
MECHANICS
Respiratory mechanics are used in COPD and emphysema as an
measure of disease severity and progression. To determine if expo-
sure to cigarette smoke and a vitamin D deficient diet influenced
lung function, 63 mice were subjected to analysis of respira-
tory mechanics using a flexiVent™ ventilator. Using the forced
oscillation methods described above, static compliance increased
significantly in CD-CSE and the VDD-CSE as compared to con-
trols (P < 0.05 for both groups; data not shown). However, there
was no significant difference in compliance between VDD-CSE
mice and CD-CSE mice; compliance was similarly elevated in
both groups. Pressure-volume loops were used to estimate Total
Lung Capacity (TLC) (Vanoirbeek et al., 2010), an important
indicator of the severity and progression of emphysema (Pauls
et al., 2010). Consistent with the measurements of compliance,
the TLC was also increased in both CD-CSE and VDD-CSE mice
compared to the control animals (CD-NS) (Figure 4). The TLC
and static compliance were elevated in the VDD-CSE mice, and
animals in this treatment group had the longest average LM . Thus,
the measurements of respiratory mechanics were consistent with
the morphometric analysis of alveolar diameters in VDD-CSE
mice. The same was not true of the CD-CSE mice in whom com-
pliance and TLC were significantly increased compared to CD-NS
animals, but LM was not increased. As noted above, the presence
FIGURE 4 | Total lung capacity (TLC) in experimental groups. Over the
course of three separate experiments, total lung capacity was determined
by flexiVent™ in 63 mice. Each point represents the data from one mouse
with 14 to 17 mice per treatment group. Horizontal bars mark medians. A
Two-Way ANOVA indicated that the mean TLC in the VDD-NS group and
the CD-CSE group was significantly greater than the mean TLC in the
control group (CD-NS) (indicated by ∗∗∗ in the figure; p = 0.001).
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of increased numbers of pigmented macrophages may have con-
founded the measurements of LM in the CD-CSE mice, but it is
also true that changes in alveolar dimensions may lag changes in
respiratory mechanics in cigarette smoke exposed mice (Rinaldi
et al., 2012).
mRNA EXPRESSION IN LUNG TISSUES IS ALTERED IN VDD-CSE MICE
Proteases and their inhibitors are involved in tissue damage in
emphysema. To begin to address the mechanisms of increased
emphysema in the VDD-CSEmice, we looked at genes previously
associated with COPD (Kang et al., 2003; Mercer et al., 2005;
Tuder et al., 2010). We did quantitative real time PCR analysis
of relative mRNA expression in the four treatment groups com-
paring gene expression of alpha-1 antitrypsin (A1AT), MMP9,
and TIMP-1, to the expression of the mouse housekeeping gene
RPL13a (MHK). While neither the CD-CSE nor the VDD-NS
group mice had a significant change in A1AT, when the two treat-
ments were combined in the VDD-CSE mice, lung expression
level of this gene, crucial in protecting the lung against devel-
opment of emphysema, was significantly decreased (Figure 5A).
MMPs and their inhibitors, TIMPs, are also important in the
pathogenesis of emphysema (Smolonska et al., 2009). While
we found a non-significant trend toward increased expression
of MMP-9 when comparing CD-NS to VDD-CSE (Figure 5B),
analyses revealed a significant drop in expression of its cognate
inhibitor, TIMP-1 (Mercer et al., 2005) only in the VDD-CSE
group (Figure 5C). The ratio of MMP-9 to TIMP-1 was signif-
icantly different comparing VDD to VDD-CSE (p = 0.05) and
CD-NS and CD-CSE to VDD-CSE (p = 0.01) (Figure 6). At the
expression level, the increase in MMP-9, the decrease in TIMP-1
and the decrease in A1AT suggest that a significant imbalance in
favor of proteolysis existed in the VDD-CSE mice.
DISCUSSION
Lifespan, period of exposure required to develop disease, as well as
heterogeneity of lifestyle and co-morbid factors preclude straight-
forward examination of the contribution of vitamin D deficiency
to development of emphysema in humans. For this reason we
developed a new, pragmatic model for the study of emphysema by
combining Vitamin D deficiency and cigarette smoke exposure in
mice. To our knowledge this is the first model to combine dietary
vitamin D deficiency and smoke exposure. We demonstrated an
effect of vitamin D deficiency and cigarette smoke exposure on
the mean linear intercept, the total lung capacity and lung com-
pliance and a shift in the protease/antiprotease balance within
the lung that favored proteolysis in this model in the vitamin D
deficient animals. Our outcomes are consistent with epidemio-
logical associations between the low Vitamin D levels, cigarette
smoke exposure and COPD. These data support a role for vita-
min D deficiency in development of emphysema, and our murine
FIGURE 5 | Bars represent the ratio ± SEM of expression of genes
to expression of the MHK housekeeping gene from whole lung in
4–8 mice from each treatment group. (A) Expression of A1AT is
significantly different in VDD-CSE mice from control mice (CD-NS)
(p = 0.0060), from CSE (p = 0.0019), and from VDD mice (p = 0.0290).
(B) While mean values of MMP-9 expression suggest an increase in
CSE and VDD-CSE treated mouse lungs, expression of MMP-9 was not
significantly different when comparing various treatment groups. (C)
Expression of TIMP-1 was significantly different in VDD-CSE mice from
CSE group (p = 0.0448).
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FIGURE 6 | Bars represent the ratio ± SEM of expression of MMP-9
divided by TIMP-1 in each animal studied. Both TIMP-1 and MMP-9 are
standardized to expression of the MHK housekeeping gene from whole
lung from four to seven mice from each treatment group. Expression of the
TIMP-1/MMP-9 ratio was significantly different comparing VDD to VDD-CSE
(p = 0.05) and CD-NS and CD-CSE to VDD-CSE (p = 0.01).
model provides a platform to study the effect of cigarette expo-
sure and vitamin D deficiency on the immunopathogenesis of this
common debilitating disease.
The importance of having a model in which to study the rela-
tionship of vitamin D deficiency to cigarette smoke induced lung
damage is supported by a number of observations. Vitamin D
deficiency occurs frequently in COPD, and the severity of vita-
min D deficiency correlates with the severity of COPD (Janssens
et al., 2009, 2010). However, whether vitamin D deficiency is a
consequence of COPD, a comorbid factor in COPD, or a con-
tributing causal risk factor in the pathogenesis of COPD cannot
be fully determined from epidemiological data. Vitamin D defi-
ciency could be a consequence of COPD since patients with
COPD spend more time indoors when compared to people of the
same age and location without COPD (Donaldson et al., 2005). In
addition, aging skin (both chronological and from smoking) and
glucocorticoids (which are prescribed frequently to patients with
COPD and may increase vitamin D metabolism) can compound
vitamin D deficiency in COPD patients (Hughes and Norton,
2009). Alternatively, vitamin D deficiency could result in skeletal
changes (Franco et al., 2009), muscle weakness (Hopkinson et al.,
2008), or propensity to infectious exacerbations (Ginde et al.,
2009); all of which are comorbid factors in COPD. Another pos-
sibility is that vitamin D deficiency, through its effects on innate
and adaptive immunity (Adams and Hewison, 2008; Hewison,
2010; Miller and Gallo, 2010), could serve as a contributing
causal, risk factor for COPD, a disease mediated at least in part
by inflammatory cell-derived proteases (Churg et al., 2008).
This model of cigarette smoke exposure was designed to
address whether low vitamin D levels can cooperate with cigarette
smoke exposure in the pathogenesis of emphysema. We demon-
strated an increased incidence of smoke-induced lung disease
in vitamin D deficient-cigarette smoke exposed mice compared
to control diet-cigarette smoke exposed mice. Specifically, mor-
phometric assessment of alveolar dimensions, using the average
alveolar size as estimated by the mean linear intercept (LM), was
significantly increased in the VDD-CSE group, which is consistent
with the occurrence of emphysema. The LM distance in the CD-
CSE mice was not increased, which was contrary to our expec-
tations. The LM , as we measured it and as is recommended by
the American Thoracic Society, measures the airspace dimensions
only. Images of representative lung sections (see Figure 2, bot-
tom left) raise the possibility that the relatively smaller LM in the
CD-CSE mice reflects both increased numbers of macrophages
(Hirama et al., 2007; Bodas et al., 2011) and less prominent or
slower developing emphysema in mice exposed to cigarette smoke
(CD-CSE) for only 16 weeks, as compared to the mice with com-
bined vitamin D deficiency and cigarette smoke exposure. The
presence of increased macrophages in the airspace of the CD-CSE
animals, which is typical of cigarette smoke exposed animals and
humans, may have caused us to underestimate the “true” LM in
the CD-CSE mice. This latter explanation is consistent with our
flexiVent™ data, which revealed increased TLC and lung compli-
ance in both CD-CSE and VDD-CSE groups. The asymmetrical
deposition of macrophages within individual alveoli may not have
altered the intrinsic elastic characteristics of the lung, which make
a major contribution to the compliance of the respiratory system
and to the TLC, but may have diminished the LM of the alveoli
with particularly heavy infiltration of macrophages.
It seems more likely to us, however, that the morphometric
changes in lung associated with cigarette smoke exposure simply
take longer to develop than the changes in respiratory mechanics
(Rinaldi et al., 2012). Emphysematous changes in lung mor-
phology usually occur in mice only after 26 weeks of cigarette
smoke exposure (Shapiro et al., 2003). Thus, we found the high-
est TLC, the highest compliance and the largest LM after only
16 weeks of cigarette smoke exposure in the vitamin D deficient
animals. The next highest average TLC and compliance mea-
surements occurred in the CD-CSE animals, though LM was not
similarly increased. Thus, adding vitamin Ddeficiency to cigarette
smoke exposure may have accelerated the development of the
pathological changes typical of emphysema so that the VDD-
CSE group had pathological evidence of emphysema after only
16 weeks of cigarette smoke exposure; whereas previous investi-
gators found that pathological evidence of emphysema appeared
in non-vitamin D deficient mice only after 26 weeks of cigarette
exposure even though changes in lung mechanics occurred after
12 weeks of cigarette smoke exposure (just as we found in the vita-
min D replete animals after 16 weeks of cigarette smoke exposure)
(Rinaldi et al., 2012). The CD-CSE mice were, in our view, devel-
oping emphysema (lung compliance and TLC were increased and
there were focal areas of emphysema; see Figure 2), but the mor-
phometric hallmark of emphysema (an increased LM) had not
developed after only 16 weeks of cigarette smoke exposure. The
possibility of accelerated emphysema formation when vitamin D
was deficient is also supported by the greater increase in expres-
sion of proteolytic enzymes compared to antiproteolytic factors
in the VDD-CSE mice compared to the mice exposed to either
vitamin D deficiency or cigarette smoke alone.
www.frontiersin.org June 2013 | Volume 4 | Article 132 | 7
Crane-Godreau et al. Modeling VDD-CSE emphysema
Vitamin D is a steroidal hormone produced mainly from
precursors within the skin via the action of ultraviolet B and avail-
able, to a lesser extent, from dietary sources. To define our model,
mice on control diets were fed standard levels of vitamin D found
in commercial mouse chow; in contrast the mice on VDD diet
had no exogenous source of vitamin D. Vitamin D is recognized
as an important hormone that controls genes with a multitude
of extra-skeletal functions through its actions as a transcription
factor (Bischoff-Ferrari, 2010; Holick, 2010) including control
of the expression of a number of genes associated with innate
immunity (Adams et al., 2007, 2009). Infectious exacerbations are
increasingly frequent in the late stages of COPD in humans and
vitamin D insufficiency or deficiency could contribute to COPD
pathogenesis by diminishing protection against lung infection.
Ongoing experiments are addressing this hypothesis.
To begin to address putative mechanisms whereby vitamin D
deficiency might contribute to our observed findings, we looked
at enzymes associated with lung remodeling and at TIMP-1, a
gene that we noted in early experiments to be altered by cigarette
smoke. MMPs have an important role in the breakdown of ECM
and may serve as markers of tissue damage in smoking related
lung diseases (Elkington and Friedland, 2006; Ilumets et al.,
2007; Louhelainen et al., 2009). TIMP-1 is a specific inhibitor
of MMP-9; low levels of TIMP-1 relative to MMP-9 suggest a
proteinase rich environment that would foster breakdown of the
extracellular matrix. The MMP-9:TIMP-1 ratio is increased in
sputum of COPD patients (Beeh et al., 2003) and plasma MMP-9
levels are inversely related to vitamin D levels (Timms et al.,
2002). It is not surprising then that vitamin D suppresses the
production of MMPs and enhances the level of tissue inhibitor
of metalloproteinase-1 (TIMP-1) (Anand and Selvaraj, 2009).
Thus, our data indicating an increase in MMP-9: TIMP-1 ratio in
vitamin D deficient smoke-exposed mice provides a mechanism
whereby vitamin D deficiency can influence and accelerate the
development of emphysema. In keeping with a role for vitamin D
deficiency in protease-antiprotease imbalance, we also found
significantly reduced A1AT levels in vitamin D-deficient smoke-
exposed mice. Alpha-1 antitrypsin deficiency (AATD) confers
susceptibility to emphysema, and polymorphisms in vitamin D-
binding protein (VDBP; also known as Gc-globulin) have been
linked to AATD (Chishimba et al., 2010).
In this study, designed to address whether low vitamin D
levels contribute directly to aspects of COPD and emphysema
pathogenesis, we found increased emphysema (increased alveo-
lar LM , increased static compliance and increased TLC and lung
compliance in the VDD-CSE treatment group) and changes in
gene expression consistent with enhanced proteolytic activity in
the lungs of vitamin D deficient-cigarette smoke exposed mice
after a relatively short duration of exposure to cigarette smoke.
Moreover, our data suggest that a protease-antiprotease imbal-
ance, which developed only after combined exposure to cigarette
smoke and a vitamin D deficient diet, may have accelerated the
development of emphysema so that the changes in lung mechan-
ics and lung pathology typical of COPD in mice developed within
16 weeks of cigarette smoke exposure in the vitamin D deficient
animals rather than the usual 26 week exposure required to gen-
erate all of these changes in previous studies in vitamin D replete,
cigarette smoke exposed mice (Shapiro et al., 2003; Rinaldi et al.,
2012). In conclusion, this work establishes a potentially use-
ful murine model to study the combined effects of vitamin D
deficiency and cigarette smoke exposure in the development of
emphysema. Ongoing studies are focusing on the interaction
of vitamin D and cigarette smoke in respiratory tract innate
immunity.
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